Contribution: Industrial Research Assistance Program – Contributions to Firms
DGI Clinical Inc.
$200,225.00
Development and Validation of New Analytical Tools for Managing Complex Drug Trial Data
FY 2017-18 · 2017-07-26
Summary
The project will develop, refine, and validate two new analytical tools that can be used to expand the Firm's analytical service offerings.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Guy|Guy, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
863915765
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 2 | 2017-07-26 | 2017-18 | $216,409.00 |
| 3 | 2017-07-26 | 2017-18 | $200,225.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -89 days. The total amendment value is -16,184 dollars.
Additional Information (French)
La date de fin du présent accord a été changé de -89 jours. Cet accord a été modifié 1 fois ou la valeur totale des modifications est de - 16 184 dollars.
Agreement End Date
2019-03-31
Agreement Number
890526
Agreement Start Date
2017-07-26
Agreement Title
Development and Validation of New Analytical Tools for Managing Complex Drug Trial Data
Agreement Title (French)
Développement et validation de nouveaux outils d'analyse pour la gestion de données complexes d'essais sur des médicaments
Agreement Type
Contribution
Agreement Value
$200,225.00
Amendment Date
2019-04-08
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project will develop, refine, and validate two new analytical tools that can be used to expand the Firm's analytical service offerings.
Description (French)
Le projet développera, raffinera et validera deux nouveaux outils analytiques pouvant être utilisés pour élargir les offres de services analytiques de l’entreprise.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Halifax
Federal Riding (French)
Halifax
Federal Riding Number
12005
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
863915765
Recipient City
Guy|Guy
Recipient Country
CA
Recipient Legal Name
DGI Clinical Inc.
Recipient Postal Code
B3J 2E3
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2018-2019-Q3-890526
